CelLBxHealth plc (AGL.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
CelLBxHealth plc
Address
4th Floor, Reading Bridge House, George Street
Guildford, RG1 8LS
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 14 8334 3434
Website
Sector
Healthcare
Industry
Medical - Distribution
Employees
119
First IPO Date
September 25, 2023
Key Executives
| Name | Title | Pay | Year Born |
| Andrew David William Newland | Founder, Chief Executive Officer & Executive Director | 281,000 | 1961 |
| Ian Francis Griffiths | Chief Financial Officer, Finance Director, Company Secretary & Executive Director | 180,000 | 1964 |
| Karen Miller | Chief Scientific Officer | 0 | N/A |
| Andrew John Holder | Head of Investor Relations | 0 | 1968 |
| Brett Swansiger | Chief Commercial Officer | 0 | N/A |
| Anne-Sophie Pailhes-Jimenez | Head of R&D and Senior Director | 0 | N/A |
| Michelle Munson | Human Resources Director | 0 | N/A |
AD
Description
CelLBxHealth Plc is a holding company, which engages in the provision of its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.
AD
